Gregory Norden's Net Worth
$5.98 Million
Who is Gregory Norden?
Gregory Norden has an estimated net worth of $5.98 Million. This is based on reported shares across multiple companies, which include Zoetis Inc., Royalty Pharma plc, Praxis Precision Medicines, Inc., NanoString Technologies Inc, Entasis Therapeutics Holdings Inc., HUMAN GENOME SCIENCES INC, WYETH, and K-V Pharmaceutical Co.
SEC CIK
Gregory Norden's CIK is 0001405104
Past Insider Trading and Trends
2023 was Gregory Norden's most active year for acquiring shares with 9 total transactions. Gregory Norden's most active month to acquire stocks was the month of January. 2009 was Gregory Norden's most active year for disposing of shares, totalling 14 transactions. Gregory Norden's most active month to dispose stocks was the month of January. 2017 saw Gregory Norden paying a total of $199,997.70 for 12,246 shares, this is the most they've acquired in one year. In 2009 Gregory Norden cashed out on 457,546.473 shares for a total of $2,621,597.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zoetis Inc. (ZTS) Snapshot price: $189.23
InvestorGregory Norden owns 3,000 units of Class A Common Stock which is worth $567,690.00. Gregory Norden used to own units in Common Stock but no longer holds any shares there. From 2013 to 2024 Gregory Norden acquired a total of 24,704.86 shares in Zoetis Inc. at a cost of $78,000.00, Gregory also disposed a total of 13,268 shares of Zoetis Inc. equalling to $770,055.03.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.21K |
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +46.92% | 1.1K |
$197.32 | -$72,416.44 | 3.43K |
Feb 10
| |||
Form 4
| +91.79% | 1.12K |
$195.75 | -$73,406.25 | 2.34K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4/A
| -90.12% | -5.32K |
—
|
—
| 583.19 |
May 15 - May 19
| |||
Form 4
| -90.12% | -5.32K |
—
|
—
| 583.19 |
May 5
| |||
Form 4
|
∞
| 1.22K |
$158.33 | -$64,598.64 | 1.22K |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
∞
| 2K |
$198.87 | -$133,441.77 | 2K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| -53.58% | -4.50K |
$216.07 | -$972,315.00 | 3.9K |
Nov 5
| |||
Form 4
| +33.01% | 2.08K |
$166.71 | -$116,196.87 | 8.39K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -47.69% | -5.62K |
—
|
—
| 6.16K |
Apr 29
| |||
Form 4
| +30.80% | 2.77K |
$144.17 | -$133,933.93 | 11.78K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +52.69% | 3.11K |
$94.91 | -$98,801.31 | 9.01K |
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +91.87% | 2.83K |
$81.67 | -$77,259.82 | 5.9K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| +38.37% | 12.72 |
—
|
—
| 45.86 |
Feb 3
| |||
Form 4
| +49.92% | 11.04 |
—
|
—
| 33.14 |
Nov 6
| |||
Form 4
| +0.74% | 22.11 |
—
|
—
| 3.02K |
Jul 24 - Sep 26
| |||
Form 4
|
∞
| 3K |
$26.00 | $78,000.00 | 3K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Royalty Pharma plc (RPRX) Snapshot price: $28.72
InvestorGregory Norden owns 73,738 units of Class A Ordinary Shares which is worth $2,117,755.36. From 2020 to 2024 Gregory Norden acquired a total of 73,738 shares in Royalty Pharma plc.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.42% | 9.29K |
—
|
—
| 73.74K |
Jun 7
| |||
Form 4
| +13.66% | 7.75K |
—
|
—
| 64.44K |
Jun 23
| |||
Form 4
| +12.56% | 6.33K |
—
|
—
| 56.7K |
Jun 24
| |||
Form 4
| +12.83% | 5.73K |
—
|
—
| 50.37K |
Jun 25
| |||
Form 4
| +25.00% | 8.93K |
—
|
—
| 44.64K |
Jun 15 - Jun 18
| |||
Form 4
|
∞
| 35.72K |
—
|
—
| 35.72K |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Praxis Precision Medicines, Inc. (PRAX) Snapshot price: $54.3
InvestorGregory Norden owns 2,826 units of Common Stock which is worth $153,451.80. From 2020 to 2024 Gregory Norden acquired a total of 2,826 shares in Praxis Precision Medicines, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
∞
| 2.83K |
—
|
—
| 2.83K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NanoString Technologies Inc (NSTG) No price found
InvestorGregory Norden owns 88,552 units of Common Stock. From 2013 to 2024 Gregory Norden acquired a total of 108,958 shares in NanoString Technologies Inc at a cost of $286,369.12, Gregory also disposed a total of 20,406 shares of NanoString Technologies Inc equalling to $995,141.84.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +86.74% | 41.13K |
—
|
—
| 88.55K |
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
| +45.60% | 14.85K |
—
|
—
| 47.42K |
Jun 17
| |||
Form 4
| +36.84% | 8.77K |
$8.45 | $74,089.60 | 32.57K |
Apr 27
| |||
Form 4
| +110.62% | 12.5K |
$9.84 | $123,000.00 | 23.8K |
Mar 7
| |||
Form 4
| +52.50% | 3.89K |
—
|
—
| 11.3K |
Jun 16 - Jun 17
| |||
Form 4
| +292.06% | 5.52K |
—
|
—
| 7.41K |
Jun 15 - Jun 16
| |||
Form 4
|
—
|
0
|
$30.12 | -$586,912.32 | 1.89K |
Dec 7
| |||
Form 4
| -84.10% | -10.00K |
$38.83 | -$388,250.00 | 1.89K |
Aug 13
| |||
Form 4
| +18.90% | 1.89K |
—
|
—
| 11.89K |
Jun 15 - Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
∞
| 10K |
$6.93 | $69,300.00 | 10K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entasis Therapeutics Holdings Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||